SCHEMBL624013

SCHEMBL624013

CC(C)(C)OC(=O)N1CCC[C@H](COS(C)(=O)=O)C1.CS(=O)(=O)O

nearest known ligand 0.56

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.54
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
GLS O94925 2/20 0.46
ACKR3 P25106 1/20 0.45
KAT7 O95251 1/20 0.43
KAT8 Q9H7Z6 1/20 0.43
KDM1A O60341 1/20 0.43
BACE1 P56817 2/20 0.42
CTSD P07339 1/20 0.42
HPGD P15428 1/20 0.42
BCHE P06276 2/20 0.42
HTR6 P50406 2/20 0.42
FEN1 P39748 2/20 0.41
ALOX5AP P20292 1/20 0.41
CYP2C9 P11712 1/20 0.41
MMP1 P03956 1/20 0.41
MMP9 P14780 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1785143 0.97 SCN9A (0.53) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL1785144 0.97 SCN9A (0.53) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL2955344 0.97 SCN9A (0.53) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL3713816 0.95 SCN9A (0.52) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL31421097 0.94 SCN9A (0.50) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL31420855 0.94 SCN9A (0.50) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL707476 0.93 SCN9A (0.50) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL2241775 0.90 GPR119 (0.47) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL613606 0.90 GPR119 (0.47) SCN9AMEN1ALDH1A1MAPTKMT2A
SCHEMBL613607 0.90 GPR119 (0.47) SCN9AMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040990-A1 INDOL-3-Y-CARBONYL-PIPERIDIN AND PIPERAZIN-DERIVATIVES BISSANTZ CATERINA (FR) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040990-A1 INDOL-3-Y-CARBONYL-PIPERIDIN AND PIPERAZIN-DERIVATIVES AVPR1A, AVPR2, OXTR SCN9A 532/4885MEN1 1220/4885ALDH1A1 1370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.